Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000433111

Medchemexpress LLC Darifenacin hydrobromide | 133099-07-7 | 99.78% | C28H31BrN2O2 | 100 MG
SDP

Catalog No. 5000433111
Encompass_Preferred

Darifenacin hydrobromide (UK-88525) is a selective and orally active antagonist of the M3 muscarinic receptor (M3R) with a pKi of 8.9. It exhibits over 20-fold greater specificity for M3R compared to other muscarinic receptors. This compound is utilized in research for studying urinary incontinence and other symptoms associated with overactive bladder. Additionally, Darifenacin hydrobromide has demonstrated inhibitory effects on tumor growth in colorectal cancer cells and possesses anti-tumor properties.

  • Selective M3 muscarinic receptor antagonist
  • Over 20-fold greater specificity for M3R
  • Used in research for urinary incontinence and overactive bladder symptoms
  • Demonstrates inhibitory effects on tumor growth in colorectal cancer cells
  • Possesses anti-tumor properties

Catalog No. 50-004-33111 Supplier Medchemexpress LLC Supplier No. HYA0012100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Darifenacin hydrobromide (UK-88525) is a selective and orally active antagonist of the M3 muscarinic receptor (M3R) with a pKi of 8.9. It exhibits over 20-fold greater specificity for M3R compared to other muscarinic receptors. This compound is utilized in research for studying urinary incontinence and other symptoms associated with overactive bladder. Additionally, Darifenacin hydrobromide has demonstrated inhibitory effects on tumor growth in colorectal cancer cells and possesses anti-tumor properties.

  • Selective M3 muscarinic receptor antagonist
  • Over 20-fold greater specificity for M3R
  • Used in research for urinary incontinence and overactive bladder symptoms
  • Demonstrates inhibitory effects on tumor growth in colorectal cancer cells
  • Possesses anti-tumor properties

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.